Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00947583 · ClinicalTrials.gov registry record
Osteocel® Plus in Transforaminal Lumbar Interbody Fusion (TLIF)
A clinical trial of Degenerative Disc Disease, sponsored by NuVasive.
- Completed
- Registry status
- 19
- Enrollment target
- 1
- Study location
NCT00947583 is a study of Degenerative Disc Disease that has completed, run by NuVasive. The registered enrollment target is 19 participants, below the 168-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00947583, a study of Degenerative Disc Disease, has completed, sponsored by NuVasive.
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being conducted to determine the percentage of patients with solid spinal fusions after being treated with Osteocel Plus in a TLIF procedure. Due to the unique processing conditions, Osteocel Plus retains a high concentration of stem cells in conjunction with the allograft bone matrix, so it is hypothesized that the fusion rate with Osteocel Plus will be comparable to published data for autograft. The Osteocel product family has already been used in approximately 15,000 cases worldwide.
Conditions Studied
Interventions
- BIOLOGICAL Osteocel Plus
Study Locations (1)
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2009-05 |
| Est. Completion | 2012-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00947583
The ClinicalTrials.gov registry entry for NCT00947583 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 168-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (89% lower). The listed sponsor is NuVasive, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Degenerative Disc Disease appearing as the primary indexed condition, and to 1 intervention - of which Osteocel Plus is the first listed.
NCT00947583 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00947583 about?
NCT00947583 is a clinical study titled "Osteocel® Plus in Transforaminal Lumbar Interbody Fusion (TLIF)". This study is being conducted to determine the percentage of patients with solid spinal fusions after being treated with Osteocel Plus in a TLIF procedure. Due to the unique processing conditions, Osteocel Plus retains a high concentration of stem cells in conjunction with the allograft bone matrix,...
What is the current status of trial NCT00947583?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2009-05. Estimated completion is 2012-10.
What conditions does trial NCT00947583 study?
This clinical trial studies the following conditions: Degenerative Disc Disease.
What interventions are being tested in trial NCT00947583?
The interventions under investigation include: Osteocel Plus (BIOLOGICAL).
Who is sponsoring clinical trial NCT00947583?
This trial is sponsored by NuVasive, which has 28 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00947583 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Degenerative Disc Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
OssDsign® Spine Registry Study ("Propel")
RECRUITING
-
A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease
RECRUITING · Phase 3
-
LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF)
RECRUITING · Phase 1
-
Investigation of DEXA-C Anterior Cervical Interbody System
RECRUITING · NA
-
Post Marketing Study of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers Mixed With Autograft in Patients Undergoing Posterolateral Lumbar Fusion
RECRUITING · NA
-
Trial for Treating Painful Degenerative Disc Disease
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.